Christine Solbach

10PUBLICATIONS
85CO-AUTHORS
Cancer cell biologyCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersCancer geneticsMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Jun 27, 2025
B-cell lymphoma 6 in breast cancer: molecular mechanisms and clinical significance.

Frank Louwen, Andreas Ritter, Nina-Naomi Kreis

|Feb 25, 2025
Neoadjuvant Paclitaxel/Olaparib in Comparison to Paclitaxel/Carboplatin in Patients with HER2-Negative Breast Cancer and HRD-Long-term Survival of the GeparOLA Study.

Peter A Fasching, Sabine Schmatloch, Jan Hauke

|Jan 30, 2025
Surrogate End Points for Overall Survival in Neoadjuvant Randomized Clinical Trials for Early Breast Cancer.

Fabio Conforti, Valentina Nekljudova, Isabella Sala

|Nov 22, 2024
Calculating Future 10-Year Breast Cancer Risks in Risk-Adapted Surveillance: A Method Comparison and Application in Clinical Practice.

Silke Zachariae, Anne S Quante, Marion Kiechle

|Jun 05, 2024
An Analysis of PIK3CA Hotspot Mutations and Response to Neoadjuvant Therapy in Patients with Breast Cancer from Four Prospective Clinical Trials.

Paul Jank, Thomas Karn, Marion van Mackelenbergh

|Feb 12, 2024
KIF2C/MCAK a prognostic biomarker and its oncogenic potential in malignant progression, and prognosis of cancer patients: a systematic review and meta-analysis as biomarker.

Nina-Naomi Kreis, Ha Hyung Moon, Linda Wordeman

Pageof 2

Frequent Collaborators

4 joint publications

Juping Yuan

4 joint publications

Nina-Naomi Kreis

4 joint publications

Andreas Ritter

3 joint publications

Johannes Holtschmidt